Ergoteles LLC Vor Biopharma Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.77 - $7.43 $160,126 - $315,581	-42,474 Reduced 65.01%	22,858 $152,000
Q3 2022 Nov 14, 2022	SELL	$3.9 - $5.52 $82,254 - $116,422	-21,091 Reduced 24.4%	65,332 $260,000
Q2 2022 Aug 12, 2022	BUY	$3.89 - $6.44 $273,945 - $453,524	70,423 Added 440.14%	86,423 $430,000
Q1 2022 May 13, 2022	BUY	$6.04 - $12.23 $96,640 - $195,680	16,000 New	16,000 $97,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.